News
Novo Nordisk slashes price of Ozempic
Digest more
Novo Nordisk, the Denmark-based pharmaceutical company that makes Ozempic and Wegovy, looks like it's being toppled off its GLP-1 throne. In a statement to Reuters, the Danish conglomerate admitted ...
GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of ...
Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...
GLP-1 receptor agonist medications like Ozempic have been talked about so much that its side effects (like nausea and ...
The Canadian Press on MSN1d
Health Canada approves Ozempic to reduce kidney decline in people with Type 2 diabetes
An international clinical trail showed the risk of kidneys deteriorating or failing was lower in patients taking Ozempic, as ...
A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.
The healthcare company will offer the GLP-1s for $499 a month, the lowest-ever out-of-pocket cost for the weight-loss ...
America’s obesity crisis extends beyond humans — studies suggest that around 60% of dogs and cats nationwide are overweight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback